The Cooper Companies, Inc. ( COO) - Key Metrics
COO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | $5.21 | $0.66 | $1.33 | $0.81 |
| 2025Q4 | $5.38 | $0.43 | $1.25 | $0.76 |
| 2025Q3 | $5.29 | $0.49 | $1.30 | $0.82 |
| 2025Q2 | $5.01 | $0.44 | $0.48 | $0.09 |
COO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | 30.60 |
| 2025Q4 | ? | 40.93 |
| 2025Q3 | ? | 36.06 |
| 2025Q2 | ? | 46.54 |
COO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.79% | ? |
| 2026Q1 | 0.99% | ? |
| 2025Q4 | 1.08% | ? |
| 2025Q3 | 1.16% | ? |
| 2025Q2 | 0.11% | ? |
COO
Price: $70.50
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.18 USD
P/E Ratio: 58.15
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 261400
Ebitda: 153.9 millionMarket Capitalization: 14.5 billion
Average Dividend Frequency: 2